Lena Innala
- Rheumatology top 2%
- Radiology, Nuclear Medicine and Imaging
- Immunology
- Cardiology and Cardiovascular Medicine
- Hematology top 10%
- Co-authors
- Solbritt Rantapää‐DahlqvistTorgny SmedbyBozena MöllerSolveig Wållberg‐JonssonStaffan MagnussonHeidi KokkonenErik JidellLotta Ljung
- Topics
- Rheumatoid Arthritis Research and Therapies (9 papers)Systemic Lupus Erythematosus Research (8 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
- Cited by
- RheumatologyHematologyDrug Discovery
- Partner nations
- SwedenUnited States
In The Last Decade
Lena Innala
11 papers receiving 616 citations
Peers
Comparison fields: 5 of 59
- Rheumatology 520
- Radiology, Nuclear Medicine and Imaging 109
- Immunology 105
- Cardiology and Cardiovascular Medicine 92
- Hematology 77
Countries citing papers authored by Lena Innala
This map shows the geographic impact of Lena Innala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Innala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Innala more than expected).
Fields of papers citing papers by Lena Innala
This network shows the impact of papers produced by Lena Innala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Innala. The network helps show where Lena Innala may publish in the future.
Co-authorship network of co-authors of Lena Innala
This figure shows the co-authorship network connecting the top 25 collaborators of Lena Innala. A scholar is included among the top collaborators of Lena Innala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Innala. Lena Innala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 3 | |
| 3 | 67 | |
| 4 | 113 | |
| 5 | Comorbidity in early rheumatoid arthritis : does inflammation matter? | 1 |
| 6 | Age at onset determines severity and choice of treatment in early rheumatoid arthritis | 1 |
| 7 | 186 | |
| 8 | Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. | 84 |
| 9 | 76 | |
| 10 | 71 | |
| 11 | Antibodies to mutated citrullinated vimentin (MCV) are a better predictor of disease activity at 24 months in rheumatoid arthritis than antibodies to cyclic citrullinated peptide (CCP). | 1 |
About Lena Innala
Lena Innala is a scholar working on Rheumatology, Hematology and Genetics, having authored 11 papers that have together received 630 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Rheumatology (520 citations), Hematology (77 citations) and Drug Discovery (1 citation). Lena Innala has collaborated with scholars based in Sweden and United States. Frequent co-authors include Solbritt Rantapää‐Dahlqvist, Torgny Smedby, Bozena Möller, Solveig Wållberg‐Jonsson, Staffan Magnusson, Heidi Kokkonen, Erik Jidell, Lotta Ljung, Anna Södergren and Ewa Berglin. Their work appears in journals such as PLoS ONE, Arthritis Research & Therapy and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.